We are live on
!
Find out more
SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.92B
1-Year Est. Return
86.67%
This Fund
S&P 500
This Quarter
Est. Return
-11.48%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.63B
AUM Growth
-$644M
(-20%)
Cap. Flow
-$229M
Cap. Flow
% of AUM
-8.7%
Top 10 Holdings %
Top 10 Hldgs %
36.43%
Holding
110
New
23
Increased
22
Reduced
18
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$62.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$46.1M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$45.9M |
| 4 |
Fidelity National Information Services
FIS
|
+$44M |
| 5 |
Royalty Pharma
RPRX
|
+$43.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$147M |
| 2 |
Microsoft
MSFT
|
+$93.8M |
| 3 |
S&P Global
SPGI
|
+$84.8M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$82.9M |
| 5 |
Johnson & Johnson
JNJ
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.33% |
| 2 | Industrials | 11.58% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Technology | 7.11% |
| 5 | Financials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Fidelity National Information Services
FIS
$22.1B
| $40.6M | 1.55% |
+443,240
| New | +$44M |
|
27
Hilton Worldwide
HLT
$73B
| $40.2M | 1.53% |
360,491
-2,212
| -0.6% | -$306K |
|
28
Marriott International
MAR
$94.2B
| $39.8M | 1.51% |
292,687
-16,553
| -5% | -$2.73M |
|
|
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $38.8M | 1.48% |
+486,661
| New | +$46.1M |
|
|
KZR
30
DELISTED
Kezar Life Sciences
KZR
| $36.5M | 1.39% |
441,230
+300,234
| +213% | +$26.5M |
|
31
McKesson
MCK
$103B
| $34.2M | 1.3% |
104,802
+6,822
| +7% | +$2.18M |
|
32
Walt Disney
DIS
$177B
| $33.1M | 1.26% |
+350,926
| New | +$38.9M |
|
33
Global Payments
GPN
$23.9B
| $31.8M | 1.21% |
+287,222
| New | +$36.3M |
|
|
KDNY
34
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $31.2M | 1.19% |
1,784,200
+350,000
| +24% | +$5.49M |
|
35
RH
RH
$3.7B
| $28.3M | 1.08% |
133,325
-48,510
| -27% | -$14.4M |
|
36
Marqeta
MQ
$1.75B
| $28.1M | 1.07% |
865,926
-146,562
| -14% | -$5.76M |
|
37
ExxonMobil
XOM
$628B
| $24.9M | 0.95% |
+290,732
| New | +$26.2M |
|
38
Sutro Biopharma
STRO
$416M
| $24.2M | 0.92% |
464,500
+91,260
| +24% | +$5.1M |
|
39
EyePoint Inc
EYPT
$1.03B
| $23.4M | 0.89% |
2,968,207
+58,800
| +2% | +$591K |
|
40
GFL Environmental
GFL
$14.9B
| $23.3M | 0.89% |
903,132
-1,381,364
| -60% | -$41M |
|
41
Monster Beverage
MNST
$92.4B
| $23.2M | 0.88% |
+499,604
| New | +$21.7M |
|
42
Crinetics Pharmaceuticals
CRNX
$8.91B
| $21M | 0.8% |
+1,125,112
| New | +$22.5M |
|
43
Ultragenyx Pharmaceutical
RARE
$2.46B
| $20.8M | 0.79% |
348,519
-176,581
| -34% | -$10.9M |
|
|
PNT
44
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $20.5M | 0.78% |
3,014,408
| – | – |
|
45
Match Group
MTCH
$8.9B
| $20.1M | 0.76% |
+287,786
| New | +$23.3M |
|
|
KALV
46
DELISTED
KalVista Pharmaceuticals
KALV
| $19M | 0.72% |
1,928,200
+181,900
| +10% | +$2.01M |
|
47
Pharvaris
PHVS
$2.34B
| $18.3M | 0.7% |
827,540
| – | – |
|
|
MRNS
48
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $17M | 0.65% |
3,510,831
+744,831
| +27% | +$4.53M |
|
49
Fulcrum Therapeutics
FULC
$288M
| $16.4M | 0.63% |
3,355,624
+742,212
| +28% | +$7.25M |
|
50
ServiceNow
NOW
$121B
| $12.1M | 0.46% |
+127,605
| New | +$12.2M |
|
Similar funds
MIM
BCP
AS
MSI
FLSM
LWCA
GAMH
TFM
Suvretta Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Suvretta Capital Management held 110 positions worth $2.63B, down 20% from $3.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Suvretta Capital Management withdrew a net $229M in Q2 2022, closing 21 positions and reducing 18 holdings. Its most notable exit was Amazon, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 47% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Suvretta Capital Management opened a new position in Block Inc worth $41.8M.
- Suvretta Capital Management's largest Q2 2022 buy was Block Inc: 679,676 shares worth $41.8M.
- Suvretta Capital Management added most to Royalty Pharma in Q2 2022, an estimated $43.2M increase.
- Suvretta Capital Management's biggest Q2 2022 reduction was Microsoft, cutting an estimated $93.8M.
- Suvretta Capital Management fully exited Amazon in Q2 2022, selling an estimated $147M.
- Suvretta Capital Management's ten largest holdings make up 36% of its $2.63B portfolio in Q2 2022.
- Suvretta Capital Management opened 23 new positions and closed 21 in Q2 2022.
- Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $2.63B.
Based on Suvretta Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.